Lazard Asset Management’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-648	Closed	-$78K	–	2631
2023 Q1	$78K	Hold	648	–	–	﹤0.01%	1631
2022 Q4	$74K	Buy	+648	New	+$74K	﹤0.01%	1644